Back to Top

Paper Title

Altered Telomeres in Tumors with ATRX and DAXX Mutations

Authors

Bert Vogelstein
Bert Vogelstein
Kenneth W. Kinzler
Kenneth W. Kinzler
Gregory J. Riggins
Gregory J. Riggins
Nickolas Papadopoulos
Nickolas Papadopoulos
Ralph H. Hruban
Ralph H. Hruban
Alan K. Meeker
Alan K. Meeker

Article Type

Research Article

Journal

Science

Research Impact Tools

Issue

Volume : 333 | Issue : 6041 | Page No : 425

Published On

July, 2022

Downloads

Abstract

The proteins encoded by ATRX and DAXX participate in chromatin remodeling at telomeres and other genomic sites. Because inactivating mutations of these genes are common in human pancreatic neuroendocrine tumors (PanNETs), we examined the telomere status of these tumors. We found that 61% of PanNETs displayed abnormal telomeres that are characteristic of a telomerase-independent telomere maintenance mechanism termed ALT (alternative lengthening of telomeres). All of the PanNETs exhibiting these abnormal telomeres had ATRX or DAXX mutations or loss of nuclear ATRX or DAXX protein. ATRX mutations also correlate with abnormal telomeres in tumors of the central nervous system. These data suggest that an alternative telomere maintenance function may operate in human tumors with alterations in the ATRX or DAXX genes.

View more >>

Uploded Document Preview